Natural Compounds to Reduce Nitrite in Meat Products (PHYTOME)

October 23, 2019 updated by: Maastricht University

Natural Compounds to Reduce Nitrite in Meat Products: PHYTOME

The PHYTOME project (Phytochemicals to reduce nitrite in meat products) is a major European Union (EU) co-funded research project that aims to develop innovative meat products in which the food additive nitrite has been replaced by natural compounds originating from fruits and vegetables. These biologically active compounds, also referred to as phytochemicals, are known to contribute to improved gut health and are added to the meat as natural extracts.

In a number of meat products, carefully selected combinations of natural antioxidants and other biologically active compounds occurring in vegetables, fruits and natural extracts such as coffee and tea, will be added during meat processing. Some of these compounds possess an antimicrobial activity allowing them to replace nitrite, whereas others possess a natural red colour that may contribute to the desired appearance of the products. Also, some of these compounds are known to protect colonic cells against damaging effects of cancer causing agents that may be formed in the large intestine after meat consumption.

The PHYTOME project will develop new technologies to introduce the natural extracts during processing to different types of meat products. These techniques will guarantee good sensory quality of the product as well as microbiological safety. Once these techniques have been developed and optimized at laboratory scale, the new type of products will be produced on an industrial scale. The health promoting effects of these products will be evaluated in a human dietary intervention study with healthy volunteers. After consumption of a fully controlled diet with either relatively high amounts of the traditional meat products or products produced following the new concept, faeces and colonic material will be collected and investigated for markers of colorectal cancer risk. These investigations will be performed in close collaboration with Research Institutes in the United Kingdom, Belgium, Italy and Greece, and will make use of the newest genomics techniques that are available.

Study Overview

Detailed Description

Rationale:

The aim of this project is to develop new meat processing technologies, resulting in innovative meat products that have low or no nitrite and that have been shown to contribute to improved human health. This will be achieved by introducing carefully selected mixtures of biologically compounds originating from natural plant extracts. The new meat products will be evaluated in a human dietary intervention study to establish their positive effect on cancer risk markers in colonic tissues using the newest genomics techniques available.

Objective:

This project aims to evaluate the health impact of newly developed low nitrite containing meat products using genomics markers in a human dietary intervention study.

Study design:

This study has a cross-over design with only healthy volunteers. Each participant will be asked to donate a urinal, faecal and blood sample and undergo endoscopy after each intervention period. All analyses will be done for each study group separately to examine the overall effects of nitrite levels in meat.

Study population:

All subjects will be recruited by the University of Maastricht (UM) in the province of Limburg, the Netherlands, using advertisements in local newspapers as well as other media. Healthy subjects of both sexes will be selected based on predefined inclusion criteria (BMI: 18-25; > 18 years) and randomly assigned to one of the different experimental groups.

Intervention (if applicable):

Subjects will receive a completely controlled diet with 3 different types of meat products according to the study design, with either normal levels, low or no added nitrite. After each of the three intervention periods of 15 days (300 grams meat per day) blood, urine, saliva, mouth wash and faeces will be sampled and stored appropriately at UM for later analysis. Additionally, colonic biopsies will be taken by the department of internal medicine (UM) or at the hospital of Sittard during an endoscopic examination. To evaluate the impact of nitrate in drinking water on the endogenous nitrosation processes in combination with processed red meat intake, there will be and extra intervention period of 7 days were volunteers will be asked to consume drinking water with high nitrate levels according to the Acceptable Daily Intake level (ADI: 3.7mg/kg bodyweight) in combination with 300 grams processed red meat per day. Also after this intervention period volunteers will be asked to collect a blood and saliva sample and 24h urine and faeces samples. Also, colonic biopsies will be taken by the department of internal medicine (UM) or at the hospital of Sittard during an endoscopic examination.

Main study parameters/endpoints:

  • Formation of N-nitrosocompounds in human faecal and urine samples
  • Reveal differences in transcriptomic and epigenomic markers after consumption of meat products enriched with natural compounds. These markers can be interpreted as an indicator of reduced cancer risk.
  • Correlating gene expression changes to changes in genotoxic endpoints (DNA damage, reduction in N-Nitroso compounds (NOC)) to reveal the molecular processes involved in cancer risk reduction. The identification of molecular pathways that are crucial in the carcinogenic process will demonstrate a causal association between dietary changes and markers of carcinogenic risk.

Study Type

Interventional

Enrollment (Actual)

78

Phase

  • Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • (Click To Select US State)
      • Maastricht, (Click To Select US State), Netherlands, 6200MD
        • Toxicogenomics

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Healthy with a Body Mass Index (BMI) between 18-25, male or female
  • Between 18-70 years old

Exclusion Criteria:

  • Alcohol abuse up to 6 months before participation in this research
  • Current aberrations or insufficiency of kidney, liver, gut, heart or lungs
  • Current presence of persistent inflammation in the gut or liver
  • Current endocrine or metabolic aberrations
  • Current anaemia or infection
  • HIV infection or hepatitis
  • Use of antibiotics and other medication over the last 3 months
  • Current smokers
  • Vegetarians
  • Pregnant women
  • Participants of other intervention studies during this intervention period.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Normal nitrite levels
Processed meat products enriched with natural compounds will contain normal nitrite levels.
300 grams per day during 2 weeks
300 grams per day during 2 weeks
300 grams per day during 2 weeks
3.7 mg nitrate/kg bw per day plus 300 grams of meat for 1 week
Experimental: Reduced nitrite levels
Processed meat products enriched with natural compounds will contain reduced nitrite levels
300 grams per day during 2 weeks
300 grams per day during 2 weeks
300 grams per day during 2 weeks
3.7 mg nitrate/kg bw per day plus 300 grams of meat for 1 week

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in N-nitroso compound (NOC) levels in faeces and urine measured as apparent total nitroso compounds (ATNC) between baseline levels at the start of the intervention and each intervention period
Time Frame: At baseline, at 2 weeks, at 4 weeks, at 6 weeks, and at 7 weeks
The faecal and urinal level of NOC is measured as Total Apparent Nitroso Compounds (ATNC) and used indicator of colonic endogenous nitrosation. It is known to significantly increase following strictly controlled diets high in red or processed meat.
At baseline, at 2 weeks, at 4 weeks, at 6 weeks, and at 7 weeks
Change in whole genome gene expression analyses in colonic biopsies and blood between baseline levels and each intervention period (transcriptomics)
Time Frame: At baseline, at 2 weeks, at 4 weeks, and at 6 weeks
Colon biopsies and blood will be analysed for transcriptomic responses to the dietary changes. This will provide information on gene expression changes in the colon epithelium that may be linked with other parameters such as faecal NOC levels. This will also identify molecular pathways that can link dietary composition to processes involved in cancer development.
At baseline, at 2 weeks, at 4 weeks, and at 6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in urinary nitrate and creatine levels between baseline levels at the start of the intervention and each intervention period.
Time Frame: At baseline, at 2 weeks, at 4 weeks, at 6 weeks, and at 7 weeks
Urine samples (0.25 mL) will be analysed for nitrate and urinary creatinine. Nitrate concentrations (ng/ml) will be divided by creatinine concentrations (mg/100ml) to adjust for the variable hydration of participants.
At baseline, at 2 weeks, at 4 weeks, at 6 weeks, and at 7 weeks
Genotyping of DNA
Time Frame: At baseline
Blood will be collected which will be used for genotyping of single nucleotide polymorphisms associated with oxidative stress, biotransformation and DNA repair. This will provide information on the relation between genetic variations linked with other tested parameters such as faecal NOC levels.
At baseline
Change in DNA methylation analyses of DNA isolated from colonic biopsies and blood (epigenetics) between baseline levels at the start of the intervention and each intervention period
Time Frame: At baseline, at 2 weeks, at 4 weeks, at 6 weeks
Colon biopsies and blood will be analysed for epigenomic responses to the dietary changes. This will provide information on the genes of which the DNA methylation status has changed which might explain their change in gene expression. Epigenetic changes and gene expression changes will be integrated during the analyses.
At baseline, at 2 weeks, at 4 weeks, at 6 weeks
Change in enzyme activity of nitrate reductase in saliva between baseline levels at the start of the intervention and each intervention period
Time Frame: At baseline, at 2 weeks, at 4 weeks, at 6 weeks, and at 7 weeks
Microorganisms in the mouth are able to convert nitrate to nitrite and it has been estimated that about 70% of ingested nitrite is formed in this way. Dietary interventions containing nitrate have shown to infuence the activity of the enzyme nitrate reductase.
At baseline, at 2 weeks, at 4 weeks, at 6 weeks, and at 7 weeks
Change in the microbiome in feacal samples and in saliva between baseline levels at the start of the intervention and each intervention period
Time Frame: At baseline, at 2 weeks, at 4 weeks, at 6 weeks, and at 7 weeks
Both saliva and fecal specimens will be used for DNA extraction and subsequent analyses. The microbiome is sensitive for dietary changes, and its composition can alter due to different exposures.
At baseline, at 2 weeks, at 4 weeks, at 6 weeks, and at 7 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in faecal water genotoxicity between baseline levels at the start of the intervention and each intervention period
Time Frame: At baseline, at 2 weeks, at 4 weeks, at 6 weeks
Faecal water can be prepared from faecal matter after which a short-term exposure of an in vitro colon cell line will be performed. DNA damage will subsequently be assessed by the alkaline single cell gel electrophoresis assay or comet assay.
At baseline, at 2 weeks, at 4 weeks, at 6 weeks
Change in O6-CMG in colonic biopsies between baseline levels at the start of the intervention and each intervention period
Time Frame: At baseline, at 2 weeks, at 4 weeks, at 6 weeks
O6-CMG is a mutagenic DNA adduct that results from exposure to nitrosated glycine derivatives and has particular potential as a biological marker of DNA carboxymethylation because it does not seem to be repaired by O6-alkylguaninealkyltransferase. O6-CMG has previously been found to increase following a diet high in red meat.
At baseline, at 2 weeks, at 4 weeks, at 6 weeks
Change in O6-MeG in colonic biopsies between baseline levels at the start of the intervention and each intervention period
Time Frame: At baseline, at 2 weeks, at 4 weeks, at 6 weeks
Exposure to certain NOCs causes O6-MeG adduct formation. O6-MeG DNA adducts are also mutagenic and have frequently been shown to occur in human CRC tissue. Samples will be analyzed at National Hellenic Research Foundation (NHRF; Greece) using an ELISA method described by Georgiadis et al.
At baseline, at 2 weeks, at 4 weeks, at 6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 17, 2014

Primary Completion (Actual)

June 30, 2015

Study Completion (Actual)

December 1, 2015

Study Registration Dates

First Submitted

January 8, 2014

First Submitted That Met QC Criteria

October 23, 2019

First Posted (Actual)

October 24, 2019

Study Record Updates

Last Update Posted (Actual)

October 24, 2019

Last Update Submitted That Met QC Criteria

October 23, 2019

Last Verified

January 1, 2014

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colon Cancer

Clinical Trials on Processed meat product

3
Subscribe